Navigation Links
Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
Date:7/15/2009

prietary MORPHODOMA((R)) technology, to improve the activity of the antibodies or develop new antibodies for potential therapeutic applications.

About Cancer Innovations, Inc.

Cancer Innovations, Inc. is a developmental stage biotechnology company dedicated to the discovery, development and commercialization of novel biopharmaceutical therapeutics, diagnostics as well as novel small molecule compound(s) with significant activity minimizing solid tumors for cancer and angiogenic diseases. The company is centered on a highly innovative and novel set of core technologies developed by its scientific founders. This exciting technology is based on proprietary discoveries concerning the importance of stromal factors uniquely present within the surrounding microenvironment of malignant tumors.

About Morphotek

Morphotek((R)), Inc., a subsidiary of Eisai Corporation of North America, is a biopharmaceutical company specializing in the development of protein and antibody products through the use of novel and proprietary technologies. The technologies have been successfully applied to a variety of molecules that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications. The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. For more information, please visit www.morphotek.com.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Re
'/>"/>

SOURCE Eisai Corporation of North America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
2. Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
3. Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
4. Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , , , , , , , , ... , , AUDIO: , A team of scientis...iversity of Arizona, Cold Spring Harbor Laboratory... the DNA of corn. The... , , Clic... , , , , , , , ,...
(Date:11/20/2009)...Spain and Latin American countries have an opportu...ectors. Researchers from the University of Valenci...on, have studied the productive fabric of the Span...at Spain,s food and plant sectors have more clout ...echnology as applied to food and plants has been o...
(Date:11/20/2009)..., , SAN DIEGO, Nov. 20 Veridi...Award in the mid-size company category at the 2009...ored by the San Diego Society for Human Resources ...l human resources practices. ,, Veridiam was on...loyee-nominated companies, honored at the recent a...
(Date:11/20/2009)..., , SEATTLE, Nov. 20 /PRNewswire-FirstCall/ ...ounced that the U.S. Food and Drug Administration ...mpany,s amended Biologics License Application (BLA...response. The FDA has assigned a Prescription Dru...ch time it will respond to Dendreon,s amended BLA....
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Spanish biotechnology should focus on food and plant sectors to be more competitive 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...g a previously reported initiative to establish a ...nding communities of Waukesha, Wauwatosa and Brook...uwatosa are already being pitched by Cellnet, the ...ison. Milwaukee,s network is being built by a diff...eals established so far, the city is essentially l...
... of Milwaukee and Associated Bank of Green Bay hav...nvest in Midwest companies. , , Tonka Bay Equity P...nd along with a roster of banks from around the co...sts in, and acquires, small businesses in manufact...d in investing in companies throughout Wisconsin, ...
... Wis. Quad Graphics, a printer of magazines, cat...ducts, has merged several software tools for clien..., ,QuadSystems is led by Steve Jaeger, who also se...on systems. "As a Quad Graphics business unit, Qua...orate IT staff, including software engineers, web ...
Other Biology Technology:
(Date:11/22/2009)...natally to tobacco smoke and during childhood to l...ing to research done at Cincinnati Children,s Hosp...up to 35 percent of ADHD cases in children between...ing both of these environmental exposures. This co...bacco and lead exposure each have their own import...
(Date:11/22/2009)...scientists have succeeded in producing the polymer...g, rather than through the use of fossil fuel base...ay now allow for the production of environmentally... the journal Biotechnology and Bioengineering to...s are molecules found in everyday life in the form...
(Date:11/22/2009)... have inventoried an astonishing abundance, divers... never known sunlight - creatures that somehow man... meters (~3 miles) below the ocean waves. , Rev...uard technologies, animals known to thrive in an e...e collection of species ranging from crabs to shri...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2Bioengineers succeed in producing plastic without the use of fossil fuels 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Nicotine May Help Spur Prediabetes 48655 1Nicotine May Help Spur Prediabetes 48655 2Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 1Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 2Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 3Study shows promise for new cancer stopping therapy 48649 1Study shows promise for new cancer stopping therapy 48649 2
...the "Evaluate the Clinical use of vitamin K Supple... (ECKO) trial, Angela Cheung and colleagues at the...y vitamin K1 supplement did not protect against ag...ver, as reported in this week,s PLoS Medicine , t...ct against fracture and cancer in postmenopausal w...
...ts had insufficient levels of vitamin D in a new s... The fraction of Parkinson,s patients with vitamin...re than patients with Alzheimer,s disease (41 perc...e results are published in the October issue of A...ence that low vitamin D is associated with Parkins...
...nic mouse heart has an astounding capacity to rege...on-mammalian species. The research, published by C... Developmental Cell , describes the previously un...lace diseased tissue through compensatory prolifer...ondria, a cell structure required for energy produ...
Other Biology News:Lack of vitamin D linked to Parkinson's disease 2Lack of vitamin D linked to Parkinson's disease 3Embryonic heart exhibits impressive regenerative capacity 2
...Solutions RNAi Services offer you a full range of ...ed design parameters, effective synthetic siRNA re...tain quality results from your siRNA experiments. ...oprietary B-Algo algorithm to define siRNA sequenc...
...e-line PowerPac 3000 power supply is the most vers...c focusing, DNA sequencing, isotachophoresis, SDS-...sis, western blotting, and submerged gel nucleic a... 3000 power supply offers enough power to run the ...
... GT and PowerPac 3000 system, 220-240 V, is used f...ical slab gel format. The system includes the modu...pable of separating nucleic acids with single base...amber (IPC) assembly (IPC and bonded inner glass p...
Optional Fixed Lens, 105 mm from Bio-Rad
Biology Products: